GUYER WILLIAM (Chief Development Officer) sold 84.1% of their position (11.77K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $423.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/24/2026ACC: 0001193125-26-122136
Officer· Chief Development Officer
Since Aug 2021
-11.77K
Net shares
Net seller
$423.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
11.77K acquired · 23.53K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11.77K
Price / share
$21.65
Trade value
$254.76K
% of position
527.4%
3/20/2026
2.23K→14K
Common Stock
Direct
Shares
−11.77K
Price / share
$36.01
Trade value
$423.73K
% of position
84.1%
3/20/2026
14K→2.23K
Total
Net shares
+0.00
Net value
-$168.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/20/2026 | M · Option Exercise | +11.77K | $21.65 | $254.76K | 527.4% | 2.23K | 14K |
| Common Stock Direct | 3/20/2026 | S · Sale | −11.77K | $36.01 | $423.73K | 84.1% | 14K | 2.23K |
| Total | +0.00 | -$168.97K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
11.77K shares
Shares
−11.77K
Strike price
21.65
Held after
210K
Exercisable
—
3/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock11.77K shares | 3/20/2026 | M · Option Exercise | −11.77K | 21.65 | — | 210K |